| Patents for C07K - Peptides (3,738) |
|---|
| 04/10/2007 | US7201904 Epitopes of hepatitis C virus |
| 04/05/2007 | WO2005014780A3 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 04/05/2007 | WO2004014938A3 Thrombopoiesis-stimulating proteins having reduced immunogenicity |
| 04/05/2007 | US20070078154 Quinoline potassium channel inhibitors |
| 04/05/2007 | US20070078092 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/04/2007 | EP1768994A2 Cyclic peptide antibiotics |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 03/29/2007 | US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 03/28/2007 | EP1766028A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/27/2007 | US7195761 Humanized antibodies that sequester abeta peptide |
| 03/27/2007 | CA2198727C Cell growth regulator |
| 03/22/2007 | WO2007031608A1 Collagen receptor i-domain binding modulators |
| 03/22/2007 | US20070065407 Interferon-Alpha Polypeptides and Conjugates |
| 03/22/2007 | CA2622616A1 Collagen receptor i-domain binding modulators |
| 03/21/2007 | CN1934127A A beta immunogenic peptide carrier conjugates and methods of producing same |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/20/2007 | US7193056 Process for purifying a compound |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | CA2223080C Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/15/2007 | WO2004072100A3 Nell peptide expression systems and bone formation activity of nell peptide |
| 03/14/2007 | EP1761560A1 Peptide-based compounds |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
| 03/08/2007 | WO2003094835A3 Fgf variants and methods for use thereof |
| 03/07/2007 | EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 03/07/2007 | EP1759196A1 Separation matrix and method of purification |
| 03/07/2007 | CN1926147A Nogo受体拮抗剂 Nogo receptor antagonist |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/01/2007 | WO2004081032A3 Novel litaf binding site peptides and methods of using the same |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1578778A4 Ghrelin analogs |
| 02/28/2007 | CN1922206A Process for the preparation of latent antithrombin iii |
| 02/28/2007 | CN1920040A Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 02/22/2007 | WO2004108748A3 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| 02/22/2007 | US20070042950 Antagonistic analogs of gh rh (2003) |
| 02/22/2007 | US20070042383 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/21/2007 | EP1754789A2 Bacillus strains and pesticidal proteins |
| 02/21/2007 | CN1916025A Analogs of parathyroid hormone |
| 02/15/2007 | WO2007017556A1 Method for detecting autoantibodies formed in rheumatoid arthritis |
| 02/15/2007 | US20070036776 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/13/2007 | US7176288 Human coagulation factor VII variants |
| 02/13/2007 | US7176279 melanocortin receptor-specific; phosphodiesterase inhibitors; erectile dysfunction |
| 02/07/2007 | EP1141308B1 Group b streptococcus proteins, and their use |
| 02/07/2007 | EP0504363B2 PURIFIED IgG ANTIBODIES |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/06/2007 | US7173004 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus |
| 02/01/2007 | US20070027177 11-(3-fluorophenyl)-9-methoxy-3,4-dihydro-2H-pyrido[1,2-b]isoquinoline-1,6-dione, used as antiarrhythmia agents |
| 02/01/2007 | US20070026485 Glycopegylation methods and proteins/peptides produced by the methods |
| 01/31/2007 | CN1906209A Stabilized alpha helical peptides and uses thereof |
| 01/31/2007 | CN1905893A Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/24/2007 | EP1745070A1 Peptide stabilization |
| 01/24/2007 | CN1901941A Conjugates of angiotensin ii and an imaging moiety |
| 01/24/2007 | CN1901930A Integrin alphaiibbeta3 specific antibodies and peptides |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/17/2007 | CN1898254A New coupling agents for peptide synthesis |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/10/2007 | EP1740609A2 Antagonism of tgf-beta superfamily receptor signaling |
| 01/10/2007 | EP1578764A4 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1893970A Beta-amyloid-analogue-cell epitop vaccine |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | US20070004631 Method for synthesis of phospholipids-PEG-biomolecule conjugates |
| 01/04/2007 | US20070003976 Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/03/2007 | EP1738770A1 Method for synthesis of phospholipids-PEG-biomolecule conjugates |
| 12/30/2006 | CA2551437A1 Method for synthesis of phospholipids-peg-biomolecule conjugates |
| 12/28/2006 | US20060293507 Crystallization of IGF-1 |
| 12/28/2006 | US20060292670 Nell peptide expression systems and bone formation activity of nell peptide |
| 12/28/2006 | US20060292629 Chimeric polypeptides and their use |
| 12/27/2006 | EP1684789A4 Mammalian t1r3 sweet taste receptors |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/27/2006 | EP1358209B1 Crystallization of igf-1 |
| 12/27/2006 | EP1280912B1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 12/26/2006 | US7153659 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |
| 12/21/2006 | US20060287510 Crystallization of IGF-1 |
| 12/21/2006 | US20060287235 Crystallization of IGF-1 |
| 12/21/2006 | US20060286545 Viral vectors with improved properties |
| 12/20/2006 | CN1879877A Tumour-specific animal proteins |
| 12/19/2006 | CA2200423C Novel estrogen receptor |
| 12/14/2006 | US20060281905 Crystallization of IGF-1 |
| 12/14/2006 | US20060281673 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 12/13/2006 | EP1731912A2 Peptide selection method |
| 12/13/2006 | CN1289526C Stem cell factor |
| 12/07/2006 | US20060276403 Agonist polypeptide of receptor for ZOT and zonulin |
| 12/07/2006 | US20060276397 Crystallization of IGF-1 |
| 12/07/2006 | US20060275316 Modulation of cxcr4 and related methods and compositions |